Loading...
PHR logo

Phreesia, Inc.NYSE:PHR Stock Report

Market Cap US$509.6m
Share Price
US$8.37
US$27.89
70.0% undervalued intrinsic discount
1Y-66.3%
7D-28.2%
Portfolio Value
View

Phreesia, Inc.

NYSE:PHR Stock Report

Market Cap: US$509.6m

Phreesia (PHR) Stock Overview

Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. More details

PHR fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance2/6
Financial Health4/6
Dividends0/6

PHR Community Fair Values

Create Narrative

See what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.

Phreesia, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Phreesia
Historical stock prices
Current Share PriceUS$8.37
52 Week HighUS$32.76
52 Week LowUS$7.77
Beta0.86
1 Month Change-32.34%
3 Month Change-48.65%
1 Year Change-66.30%
3 Year Change-72.55%
5 Year Change-84.08%
Change since IPO-66.63%

Recent News & Updates

Recent updates

Phreesia: Profitable At Last, Priced Like It Isn't

Dec 22

Phreesia, Inc.'s (NYSE:PHR) 26% Cheaper Price Remains In Tune With Revenues

Sep 27
Phreesia, Inc.'s (NYSE:PHR) 26% Cheaper Price Remains In Tune With Revenues
User avatar

Digital Healthcare Tools Will Expand Market Reach

Expanding digital adoption and data-driven solutions are driving operational efficiency, deeper client relationships, and long-term recurring revenue growth.

Revenues Tell The Story For Phreesia, Inc. (NYSE:PHR)

Apr 29
Revenues Tell The Story For Phreesia, Inc. (NYSE:PHR)

Why Phreesia, Inc. (NYSE:PHR) Could Be Worth Watching

Mar 07
Why Phreesia, Inc. (NYSE:PHR) Could Be Worth Watching

Phreesia (NYSE:PHR) Has Debt But No Earnings; Should You Worry?

Feb 14
Phreesia (NYSE:PHR) Has Debt But No Earnings; Should You Worry?

Phreesia, Inc.'s (NYSE:PHR) Shares Climb 27% But Its Business Is Yet to Catch Up

Dec 27
Phreesia, Inc.'s (NYSE:PHR) Shares Climb 27% But Its Business Is Yet to Catch Up

Phreesia Has Turned The Corner, Can It Continue To Mend?

Dec 12

Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues

Nov 07
Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues

Is Phreesia (NYSE:PHR) Weighed On By Its Debt Load?

Oct 08
Is Phreesia (NYSE:PHR) Weighed On By Its Debt Load?

Here's What Analysts Are Forecasting For Phreesia, Inc. (NYSE:PHR) After Its Second-Quarter Results

Sep 06
Here's What Analysts Are Forecasting For Phreesia, Inc. (NYSE:PHR) After Its Second-Quarter Results

Phreesia: Remain Bullish Given The Healthy Growth Outlook

Sep 05

Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues Pushing Shares 26% Higher

Jul 18
Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues Pushing Shares 26% Higher

Phreesia: Growth Remains Strong, With EBITDA Margin Set To Improve

Jun 06

The Price Is Right For Phreesia, Inc. (NYSE:PHR)

May 25
The Price Is Right For Phreesia, Inc. (NYSE:PHR)

Are Investors Undervaluing Phreesia, Inc. (NYSE:PHR) By 39%?

May 03
Are Investors Undervaluing Phreesia, Inc. (NYSE:PHR) By 39%?

At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?

Apr 12
At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?

Phreesia Continues To Stay Positive On The Business Growth

Apr 03

Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation

Mar 01

Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)

Feb 16
Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)

Shareholder Returns

PHRUS Healthcare ServicesUS Market
7D-28.2%-3.7%-0.3%
1Y-66.3%-35.3%16.1%

Return vs Industry: PHR underperformed the US Healthcare Services industry which returned -35.3% over the past year.

Return vs Market: PHR underperformed the US Market which returned 16.1% over the past year.

Price Volatility

Is PHR's price volatile compared to industry and market?
PHR volatility
PHR Average Weekly Movement9.7%
Healthcare Services Industry Average Movement9.9%
Market Average Movement7.1%
10% most volatile stocks in US Market16.4%
10% least volatile stocks in US Market3.3%

Stable Share Price: PHR has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: PHR's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20051,789Chaim Indigwww.phreesia.com

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks.

Phreesia, Inc. Fundamentals Summary

How do Phreesia's earnings and revenue compare to its market cap?
PHR fundamental statistics
Market capUS$509.59m
Earnings (TTM)US$2.31m
Revenue (TTM)US$480.59m
220.2x
P/E Ratio
1.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHR income statement (TTM)
RevenueUS$480.59m
Cost of RevenueUS$154.12m
Gross ProfitUS$326.47m
Other ExpensesUS$324.16m
EarningsUS$2.31m

Last Reported Earnings

Jan 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.038
Gross Margin67.93%
Net Profit Margin0.48%
Debt/Equity Ratio27.5%

How did PHR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/02 21:29
End of Day Share Price 2026/04/02 00:00
Earnings2026/01/31
Annual Earnings2026/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Phreesia, Inc. is covered by 23 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Glen SantangeloBarclays
Zhilin LongBerenberg